Skip to main content
IRIDEX Corporation (IRIX)
NASDAQ: IRIX · Real-Time Price · USD
1.740
-0.040 (-2.25%)
Nov 20, 2024, 4:00 PM EST - Market closed

IRIDEX Revenue

IRIDEX had revenue of $11.58M in the quarter ending September 28, 2024, a decrease of -9.88%. This brings the company's revenue in the last twelve months to $48.43M, down -11.31% year-over-year. In the year 2023, IRIDEX had annual revenue of $51.87M, down -8.96%.

Revenue (ttm)
$48.43M
Revenue Growth
-11.31%
P/S Ratio
0.59
Revenue / Employee
$436,315
Employees
111
Market Cap
28.95M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 30, 202351.87M-5.10M-8.96%
Dec 31, 202256.97M3.07M5.69%
Jan 1, 202253.90M17.56M48.30%
Jan 2, 202136.35M-7.10M-16.34%
Dec 28, 201943.45M847.00K1.99%
Dec 29, 2018 Pro Pro Pro
Dec 30, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Jan 2, 2016 Pro Pro Pro
Jan 3, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Tonix Pharmaceuticals Holding 11.29M
DURECT 8.59M
Marker Therapeutics 5.40M
IceCure Medical 3.34M
NeurAxis 2.46M
SAB Biotherapeutics 1.51M
OneMedNet 1.02M
Revenue Rankings

IRIX News

More News